Role of Acetaldehyde in Mediating the Pharmacological and Behavioral Effects of Alcohol
Overview
Authors
Affiliations
Acetaldehyde is the first active breakdown product (i.e., metabolite) generated during alcohol metabolism. It has toxic properties but also exerts other actions on the body (i.e., has pharmacological properties). Recent studies have shown that the direct administration of acetaldehyde, especially into the brain, induces several effects that mimic those of alcohol. High doses of acetaldehyde induce sedative as well as movement- and memory-impairing effects, whereas lower doses produce behavioral effects (e.g., stimulation and reinforcement) that are characteristic of addictive drugs. When acetaldehyde accumulates outside the brain (i.e., in the periphery), adverse effects predominate and prevent further alcohol drinking. To investigate the role of acetaldehyde in mediating alcohol's effects, investigators have pharmacologically manipulated alcohol metabolism and the production of acetaldehyde within the body (i.e., endogenous acetaldehyde production). Studies manipulating the activity of the enzyme catalase, which promotes acetaldehyde production in the brain, suggest that acetaldehyde contributes to many behavioral effects of alcohol, especially its stimulant properties. However, it remains controversial whether acetaldehyde concentrations obtained under normal physiological conditions are sufficient to induce significant pharmacological effects. Current evidence suggests that the contribution of acetaldehyde to alcohol's effects is best explained by a process in which acetaldehyde modulates, rather than mediates, some of alcohol's effects.
Perez L, Ruderman A, Useglio M, Ramallo V, Paschetta C, De Azevedo S Biomedica. 2024; 44(4):510-523.
PMID: 39531551 PMC: 11781604. DOI: 10.7705/biomedica.7270.
Gonzalez H, Misare K, Mendenhall T, Wolf B, Mulholland P, Gordon K Biochem Biophys Res Commun. 2024; 734:150735.
PMID: 39357336 PMC: 11540131. DOI: 10.1016/j.bbrc.2024.150735.
Soremekun O, Dib M, Rajasundaram S, Fatumo S, Gill D Camb Prism Precis Med. 2024; 1:e8.
PMID: 38550935 PMC: 10953756. DOI: 10.1017/pcm.2022.13.
Ben-Azu B, Moke E, Chris-Ozoko L, Jaiyeoba-Ojigho E, Adebayo O, Ajayi A Psychopharmacology (Berl). 2024; 241(4):785-803.
PMID: 38311692 DOI: 10.1007/s00213-023-06509-1.
Alcohol metabolism in alcohol use disorder: a potential therapeutic target.
Lehner T, Gao B, Mackowiak B Alcohol Alcohol. 2023; 59(1).
PMID: 37950904 PMC: 10783952. DOI: 10.1093/alcalc/agad077.